About Careers Internship MedBlog Contact us

Third Generation Drug Gets FDA Nod

by Dr. Sunil Shroff on November 17, 2007 at 5:56 PM
Third Generation Drug Gets FDA Nod

Chennai-based pharmaceuticals major Orchid Chemicals & Pharmaceuticals Ltd has received approval from the Food and Drug Administration (FDA) of the US for its infectious diseases drug.

The company said in a release Friday that the FDA has approved its abbreviated new drug application for Cefpodoxime Proxetil tablets.


The product is available in two dosage strengths of 100 mg and 200 mg.

Cefpodoxime Proxetil is a third-generation cephalosporin antibiotic, which has broad-spectrum activity against organisms causing infectious diseases.

With limited generic competition in this product, Orchid hopes to garner a sizeable market share and revenues in the US market, the company said Friday.

Source: IANS
Font : A-A+



Recommended Readings

Latest Drug News

Projected Growth: Psychedelic Drug Market Anticipated to Hit $7.2 Billion by 2029
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
ADHD Medication Errors Surge by Nearly 300%
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
Unknown Medication Side Effects Reported by 52% of Indian Families
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Third Generation Drug Gets FDA Nod Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests